AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine (Adjuvanted RSVPreF3): Review of the First 2 Years of Post-Marketing Safety Surveillance

Drug Safety · Published 2026-08-01 · DOI 10.1007/s40264-026-01698-y

Free full text

Authors (5)

Catherine Tregunno, Quentin Deraedt, Susanna Cuadripani, Céline Verheust, Philip Bryan

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Tregunno, C., Deraedt, Q., Cuadripani, S., et al. (2026). AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine (Adjuvanted RSVPreF3): Review of the First 2 Years of Post-Marketing Safety Surveillance. Drug Safety. https://doi.org/10.1007/s40264-026-01698-y

Related articles

• Perspective on Better Access to Data and Data Integration in Pharmacovigilance: Information from a Focus Group · Drug Safety · 2026 · Same journal
• A Large Language Model for Extracting Post-marketing Adverse Drug Events from Clinical Notes in the Electronic Health Record · Drug Safety · 2026 · Same journal
• Pharmacovigilance Through Fresh Eyes: The International Society of Pharmacovigilance Student Community's Role in Shaping the Future of Pharmacovigilance · Drug Safety · 2026 · Same journal
• Reliability of Self-Reported Maternal Health and Mother–Infant Outcome Data in Web-Based Questionnaires · Drug Safety · 2026 · Same journal
• Liver Safety of the Dual Neurokinin-1/-3 Receptor Antagonist Elinzanetant · Drug Safety · 2026 · Same journal
• MCSG: A Method for Simultaneous Disproportionality Analysis and Background Rate Estimation in Large Pharmacovigilance Databases · Drug Safety · 2025 · Same journal
• Pharmacovigilance Due Diligence in Drug Development: A Practical Playbook for Risk Identification, Compliance Assessment, and Strategic Decision Making · Drug Safety · 2025 · Same journal
• US Risk Evaluation and Mitigation Strategies with Elements to Assure Safe Use: A Longitudinal Analysis of REMS Modifications (2008–2022) · Drug Safety · 2026 · Same journal
• GP Consultations for Herpes Zoster After COVID-19 Vaccination: A Self-Controlled Cohort Study Based on Electronic Health Record Data from the Netherlands · Drug Safety · 2025 · Same journal
• Health Information Exchanges (HIEs) as Novel Sources for Population-Based Post Marketing Surveillance of Medical Products: A Pilot Study from the FDA Sentinel Innovation Center · Drug Safety · 2026 · Same journal